Atherosclerosis: Diet and Drugs

¡ Handbook of Experimental Pharmacology āĻŦāĻ‡ 170 ¡ Springer Science & Business Media
ā§Ģ.ā§Ļ
ā§¨āĻŸāĻŋ āĻ°āĻŋāĻ­āĻŋāĻ‰
āĻ‡-āĻŦā§āĻ•
816
āĻĒā§ƒāĻˇā§āĻ āĻž
āĻ°ā§‡āĻŸāĻŋāĻ‚ āĻ“ āĻ°āĻŋāĻ­āĻŋāĻ‰ āĻ¯āĻžāĻšāĻžāĻ‡ āĻ•āĻ°āĻž āĻšā§ŸāĻ¨āĻŋ  āĻ†āĻ°āĻ“ āĻœāĻžāĻ¨ā§āĻ¨

āĻāĻ‡ āĻ‡-āĻŦā§āĻ•ā§‡āĻ° āĻŦāĻŋāĻˇā§Ÿā§‡

Cardiovascular diseases continue to be the leading cause of death in the - jority of industrialized countries. The most frequent underlying pathology, namely atherosclerosis, and its clinical sequelae, namely coronary heart d- ease, cerebrovascular disease and peripheral artery disease, remain common although for a long time we have been made aware of avoidable or mo- ?able etiological factors such as smoking, fat-rich diet or lack of exercise, and although these adverse lifestyle factors have been extensively addressed by population-wide primary prevention programs. Cardiovascular morbidity and mortality also remain high despite successful anti-hypertensive and lipid lowering drug therapies which help to reduce cardiovascular morbidity and mortality by about 30% in both secondary and tertiary prevention settings. This can partly be explained by the increasing life expectancy and growing p- portionofelderly people,especiallyinEuropeandNorthAmerica. Inaddition, the World Health Organization makes the alarming prediction that probably in response to the spreading of western dietary behavior and lack of exercise resulting in an increasing prevalence of diabetes, dyslipidemia and hypert- sion, cardiovascular diseases rather than infectious diseases will become the most frequent cause of death worldwide. This volume of the Handbook of Experimental Pharmacology entitled “Atherosclerosis” is divided into four parts and intends to give an overview on the pathogenesis of atherosclerosis, established treatment and prevention regimen, and of perspectives for the development of new treatment modalities.

āĻ°ā§‡āĻŸāĻŋāĻ‚ āĻ“ āĻĒāĻ°ā§āĻ¯āĻžāĻ˛ā§‹āĻšāĻ¨āĻžāĻ—ā§āĻ˛āĻŋ

ā§Ģ.ā§Ļ
ā§¨āĻŸāĻŋ āĻ°āĻŋāĻ­āĻŋāĻ‰

āĻ‡-āĻŦā§āĻ•ā§‡ āĻ°ā§‡āĻŸāĻŋāĻ‚ āĻĻāĻŋāĻ¨

āĻ†āĻĒāĻ¨āĻžāĻ° āĻŽāĻ¤āĻžāĻŽāĻ¤ āĻœāĻžāĻ¨āĻžāĻ¨āĨ¤

āĻĒāĻ āĻ¨ āĻ¤āĻĨā§āĻ¯

āĻ¸ā§āĻŽāĻžāĻ°ā§āĻŸāĻĢā§‹āĻ¨ āĻāĻŦāĻ‚ āĻŸā§āĻ¯āĻžāĻŦāĻ˛ā§‡āĻŸ
Android āĻāĻŦāĻ‚ iPad/iPhone āĻāĻ° āĻœāĻ¨ā§āĻ¯ Google Play āĻŦāĻ‡ āĻ…ā§āĻ¯āĻžāĻĒ āĻ‡āĻ¨āĻ¸ā§āĻŸāĻ˛ āĻ•āĻ°ā§āĻ¨āĨ¤ āĻāĻŸāĻŋ āĻ†āĻĒāĻ¨āĻžāĻ° āĻ…ā§āĻ¯āĻžāĻ•āĻžāĻ‰āĻ¨ā§āĻŸā§‡āĻ° āĻ¸āĻžāĻĨā§‡ āĻ…āĻŸā§‹āĻŽā§‡āĻŸāĻŋāĻ• āĻ¸āĻŋāĻ™ā§āĻ• āĻšā§Ÿ āĻ“ āĻ†āĻĒāĻ¨āĻŋ āĻ…āĻ¨āĻ˛āĻžāĻ‡āĻ¨ āĻŦāĻž āĻ…āĻĢāĻ˛āĻžāĻ‡āĻ¨ āĻ¯āĻžāĻ‡ āĻĨāĻžāĻ•ā§āĻ¨ āĻ¨āĻž āĻ•ā§‡āĻ¨ āĻ†āĻĒāĻ¨āĻžāĻ•ā§‡ āĻĒā§œāĻ¤ā§‡ āĻĻā§‡ā§ŸāĨ¤
āĻ˛ā§āĻ¯āĻžāĻĒāĻŸāĻĒ āĻ“ āĻ•āĻŽā§āĻĒāĻŋāĻ‰āĻŸāĻžāĻ°
Google Play āĻĨā§‡āĻ•ā§‡ āĻ•ā§‡āĻ¨āĻž āĻ…āĻĄāĻŋāĻ“āĻŦā§āĻ• āĻ†āĻĒāĻ¨āĻŋ āĻ•āĻŽā§āĻĒāĻŋāĻ‰āĻŸāĻžāĻ°ā§‡āĻ° āĻ“ā§Ÿā§‡āĻŦ āĻŦā§āĻ°āĻžāĻ‰āĻœāĻžāĻ°ā§‡ āĻļā§āĻ¨āĻ¤ā§‡ āĻĒāĻžāĻ°ā§‡āĻ¨āĨ¤
eReader āĻāĻŦāĻ‚ āĻ…āĻ¨ā§āĻ¯āĻžāĻ¨ā§āĻ¯ āĻĄāĻŋāĻ­āĻžāĻ‡āĻ¸
Kobo eReaders-āĻāĻ° āĻŽāĻ¤ā§‹ e-ink āĻĄāĻŋāĻ­āĻžāĻ‡āĻ¸ā§‡ āĻĒāĻĄāĻŧāĻ¤ā§‡, āĻ†āĻĒāĻ¨āĻžāĻ•ā§‡ āĻāĻ•āĻŸāĻŋ āĻĢāĻžāĻ‡āĻ˛ āĻĄāĻžāĻ‰āĻ¨āĻ˛ā§‹āĻĄ āĻ“ āĻ†āĻĒāĻ¨āĻžāĻ° āĻĄāĻŋāĻ­āĻžāĻ‡āĻ¸ā§‡ āĻŸā§āĻ°āĻžāĻ¨ā§āĻ¸āĻĢāĻžāĻ° āĻ•āĻ°āĻ¤ā§‡ āĻšāĻŦā§‡āĨ¤ āĻŦā§āĻ¯āĻŦāĻšāĻžāĻ°āĻ•āĻžāĻ°ā§€āĻ° āĻ‰āĻĻā§āĻĻā§‡āĻļā§āĻ¯ā§‡ āĻ¤ā§ˆāĻ°āĻŋ āĻ¸āĻšāĻžā§ŸāĻ¤āĻž āĻ•ā§‡āĻ¨ā§āĻĻā§āĻ°āĻ¤ā§‡ āĻĻā§‡āĻ“ā§ŸāĻž āĻ¨āĻŋāĻ°ā§āĻĻā§‡āĻļāĻžāĻŦāĻ˛ā§€ āĻ…āĻ¨ā§āĻ¸āĻ°āĻŖ āĻ•āĻ°ā§‡ āĻ¯ā§‡āĻ¸āĻŦ eReader-āĻ āĻĢāĻžāĻ‡āĻ˛ āĻĒāĻĄāĻŧāĻž āĻ¯āĻžāĻŦā§‡ āĻ¸ā§‡āĻ–āĻžāĻ¨ā§‡ āĻŸā§āĻ°āĻžāĻ¨ā§āĻ¸āĻĢāĻžāĻ° āĻ•āĻ°ā§āĻ¨āĨ¤

āĻ¸āĻŋāĻ°āĻŋāĻœ āĻĒāĻĄāĻŧāĻž āĻšāĻžāĻ˛āĻŋā§Ÿā§‡ āĻ¯āĻžāĻ¨

āĻāĻ•āĻ‡ āĻ§āĻ°āĻ¨ā§‡āĻ° āĻ‡-āĻŦā§āĻ•